Automated Suturing Devices Market

Automated Suturing Devices Market Size, Market Forecast and Outlook By FMI

Summary of the Automated Suturing Devices Market

• Demand and Growth Drivers
  • Growth in minimally invasive surgical procedures is sustaining demand for automated suturing devices that enable precise tissue approximation through small incisions with reduced operative time.
  • Infection control protocols and regulatory mandates are driving adoption of single use disposable suturing devices that eliminate reprocessing risks and cross contamination concerns in surgical settings.
  • Surgical workforce efficiency pressures are accelerating procurement of automated suturing systems that reduce manual suturing time and standardize closure quality across varying surgeon skill levels.
• Product and Segment View
  • Disposable devices are expected to account for 80.6% of the product segment in 2026, driven by infection control mandates and single use regulatory requirements across hospital and ambulatory surgical settings.
  • Minimally Invasive Surgeries hold 75.8% of the application segment, reflecting the concentration of automated suturing device use in laparoscopic, thoracoscopic, and robotic assisted procedures.
  • Hospitals remain the primary end use setting for automated suturing device procurement, supported by high surgical volumes and capital equipment budgets that accommodate automated device adoption.
• Geography and Competitive Outlook
  • South Korea and the USA are each expected to register a CAGR of 7.2% through 2036, supported by high surgical volumes, MIS adoption rates, and hospital investment in surgical automation technology.
  • Japan at 7.1% reflects advanced surgical infrastructure, early adoption of robotic surgical platforms, and strong domestic medical device manufacturing capabilities.
  • Medtronic plc and Ethicon (Johnson and Johnson) lead through comprehensive surgical suturing portfolios spanning manual, powered, and automated closure systems.
• Analyst Opinion
  • 'Automated suturing devices are transitioning from specialty surgical tools to standard operating room infrastructure. Organizations that can deliver consistent closure quality, reduced procedure time, and compatibility with robotic surgical platforms are positioned to capture growing share during the forecast period,' says Sabyasachi Ghosh, Managing Director at FMI.
  • The market is evolving from manual suturing supplementation toward integrated automated closure solutions that work within robotic surgical ecosystems.
  • Adoption is increasing due to demonstrated clinical benefits including reduced operative time, standardized closure quality, and lower rates of wound complications compared to manual suturing techniques.
  • Demand is further shaped by ambulatory surgical center growth, where procedure efficiency requirements favor automated devices that reduce suturing time in outpatient surgical settings.

Key Takeaways, Market Size, and Forecast

• The automated suturing devices market was valued at USD 3.6 billion in 2025.
• The market is set to reach USD 3.8 billion by 2026-end and grow at a CAGR of 6.9% between 2026-2036 to reach USD 7.5 billion by 2036.
• Disposable will dominate with an 80.6% share, driven by infection control protocols and single-use regulatory mandates in surgical settings that favor disposable suturing devices over reusable alternatives.
• Minimally invasive surgeries will lead with a 75.8% share.
• By 2036, the automated suturing devices market is expected to be worth USD 7.50 billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 6.9%.
• The market is projected to create an incremental opportunity of USD 3.65 billion between 2026 and 2036.
• South Korea (7.2%) and USA (7.2%) are two of the fastest growing markets in the world.

Automated Suturing Devices Market Definition

The Automated Suturing Devices Market covers powered and mechanized suturing instruments used for tissue approximation and wound closure in surgical procedures. Products include disposable and reusable automated suturing devices used in minimally invasive surgeries, open surgeries, and trauma cases across hospital, clinic, and ambulatory surgical center settings.

Automated Suturing Devices Market Inclusions

Market scope includes all commercially traded automated suturing devices classified by product (disposable, reusable), application (minimally invasive surgeries, open surgeries, trauma cases), end use (hospitals, clinics, ambulatory surgical centers), and surgery type (open surgery, minimally invasive surgery). Revenue coverage spans 2026 to 2036.

Automated Suturing Devices Market Exclusions

The scope does not include manual suturing instruments, standard surgical staplers, adhesive wound closure products, or surgical mesh and tissue reinforcement products used without automated suturing mechanisms.

Automated Suturing Devices Market Research Methodology

• Primary Research: FMI analysts conducted interviews with industry participants, technology providers, and end users across key markets.
• Desk Research: Combined data from industry associations, regulatory filings, and manufacturer disclosures.
• Market Sizing and Forecasting: Bottom up aggregation across segments and regions with top down validation.
• Data Validation: Cross checked quarterly against industry data and manufacturer disclosures.

Why is the Automated Suturing Devices Market Growing?

• Minimally invasive surgery volume growth across general surgery, gynecology, urology, and thoracic specialties is creating sustained demand for automated suturing devices designed for laparoscopic and robotic port access.
• Robotic surgical platform proliferation is expanding the addressable market for automated suturing devices compatible with da Vinci, Hugo, and other robotic surgical systems.

Demand for automated suturing devices reflects the ongoing shift toward minimally invasive surgical approaches that require specialized instruments for tissue closure through restricted access ports. Manual intracorporeal suturing in laparoscopic and robotic procedures is technically demanding and time consuming, creating a clear clinical and economic rationale for automated devices that simplify and accelerate the closure process. Surgeons performing high volume MIS procedures increasingly view automated suturing as essential rather than optional equipment.

The disposable product category dominates procurement as hospital infection control committees mandate single use instruments for internal tissue closure. Reprocessing risks associated with complex automated mechanical devices, combined with regulatory requirements for sterility assurance, have shifted the market decisively toward disposable formats. This trend increases the per procedure revenue opportunity for device manufacturers while creating recurring revenue streams from surgical volume.

Robotic surgical platform integration represents the fastest growing demand driver. As robotic surgery adoption expands beyond urology into general surgery, gynecology, and thoracic specialties, the need for automated suturing devices compatible with robotic instrument interfaces is growing. Device manufacturers that develop suturing systems specifically designed for robotic surgical workflows are capturing premium pricing and establishing early platform integration advantages.

Market Segmentation Analysis

• Disposable accounts for 80.6% of the product segment, reflecting infection control mandates and the shift toward single use surgical instruments in automated closure applications.
• Minimally Invasive Surgeries hold 75.8% of the application segment, driven by growing surgical volumes in laparoscopic and robotic procedures requiring automated tissue closure solutions.

The Automated Suturing Devices Market is segmented by product, application, end use, and surgery type. Disposable devices dominate product demand, reflecting infection control requirements. Minimally Invasive Surgeries lead the application segment as the primary clinical context for automated suturing device utilization.

Insights into the Disposable Product Segment

In 2026, Disposable is expected to represent 80.6% of the product segment. Single use automated suturing devices eliminate reprocessing requirements and cross contamination risks, aligning with hospital infection control protocols and regulatory mandates for sterile surgical instrument use.

Growth reflects the increasing hospital preference for single use surgical devices across all instrument categories, supported by clinical evidence demonstrating consistent device performance and reduced surgical site infection rates compared to reprocessed alternatives.

Insights into the Minimally Invasive Surgeries Application Segment

Minimally Invasive Surgeries accounts for 75.8% of the application segment in 2026. This category covers automated suturing device use in laparoscopic, thoracoscopic, and robotic assisted procedures where tissue closure must be performed through small incisions using specialized instruments.

Growth in this segment reflects the expanding scope of MIS across surgical specialties and the growing complexity of procedures being performed minimally invasively, which increases the demand for reliable automated closure solutions.

Automated Suturing Devices Market Drivers, Restraints, and Opportunities

• MIS volume growth and robotic surgery adoption are creating sustained demand for automated suturing devices across expanding surgical specialty applications.
• High per unit device costs and procedure volume thresholds limit adoption in cost constrained surgical settings and lower volume facilities.
• Robotic surgical platform integration is creating new product development opportunities for manufacturers that can deliver compatible automated suturing systems.

The Automated Suturing Devices Market is shaped by MIS adoption, infection control requirements, and robotic surgery integration. Growth is supported by surgical volume expansion, while cost barriers limit penetration in resource constrained settings.

Minimally Invasive Surgery Expansion

Demand is shaped by the continuing shift from open to minimally invasive surgical approaches across general surgery, gynecology, urology, and cardiothoracic specialties. Each new MIS procedure adoption creates incremental demand for specialized automated suturing instruments designed for port access surgery.

Device Cost and Volume Thresholds

Adoption is constrained by the per unit cost of disposable automated suturing devices, which exceeds manual suturing instrument costs significantly. Lower volume surgical facilities and cost constrained healthcare settings may not achieve the procedure volumes necessary to justify automated device procurement.

Robotic Surgery Platform Integration

Growth reflects the proliferation of robotic surgical platforms that create demand for compatible automated suturing devices. Manufacturers developing suturing systems designed for robotic instrument interfaces are establishing early integration advantages and capturing premium pricing in the fastest growing surgical technology segment.

Analysis of Automated Suturing Devices Market By Key Countries

Country	CAGR
South Korea	7.2%
USA	7.2%
Japan	7.1%
European Union	6.9%
UK	6.8%

• South Korea and the USA lead with 7.2% CAGRs through 2036, driven by high MIS adoption rates, robotic surgery investment, and advanced hospital surgical infrastructure.
• Japan at 7.1% reflects early robotic surgery adoption, high surgical volumes, and strong domestic medical device manufacturing.
• The European Union (6.9%) and UK (6.8%) show steady growth supported by MIS standardization and robotic surgery program expansion.

The global Automated Suturing Devices Market is projected to grow at a CAGR of 6.9% from 2026 to 2036. The analysis covers more than 30 countries, with the primary markets listed below.

Demand Outlook for Automated Suturing Devices Market in South Korea

South Korea is expected to grow at 7.2% through 2036. Growth reflects advanced surgical infrastructure, high MIS adoption rates, and growing robotic surgery investment across major hospital networks.

• High MIS adoption rates sustain demand for specialized automated closure instruments.
• Robotic surgery investment creates demand for platform compatible suturing devices.
• Advanced hospital infrastructure supports procurement of premium surgical automation technology.

Future Outlook for Automated Suturing Devices Market in the United States

The USA is expected to grow at 7.2% through 2036. Demand reflects high surgical volumes, extensive robotic surgery adoption, and ambulatory surgical center growth requiring efficient closure solutions.

• High surgical volumes sustain procurement of disposable automated suturing devices across hospital networks.
• Robotic surgery adoption expands the addressable market for compatible automated closure systems.
• Ambulatory surgical center growth drives demand for time efficient automated suturing in outpatient procedures.

Opportunity Analysis of Automated Suturing Devices Market in Japan

Japan is expected to grow at 7.1% through 2036. Growth reflects early robotic surgical platform adoption, high procedural standards, and strong domestic medical device manufacturing capabilities.

• Early robotic surgery adoption creates demand for compatible automated suturing instruments.
• High procedural standards drive preference for automated closure systems that ensure consistent quality.
• Domestic medical device manufacturing supports localized automated suturing device production.

In-depth Analysis of Automated Suturing Devices Market in the European Union

The European Union is expected to grow at 6.9% through 2036. Demand reflects MIS standardization across surgical specialties, robotic surgery program expansion, and infection control driven preference for disposable devices.

• MIS standardization drives adoption of automated suturing across expanding surgical specialty applications.
• Robotic surgery program expansion creates demand for platform integrated closure solutions.
• Infection control protocols sustain procurement preference for single use disposable devices.

Sales Analysis of Automated Suturing Devices Market in the United Kingdom

The UK is expected to grow at 6.8% through 2036. Growth reflects NHS surgical modernization, expanding MIS capabilities, and increasing adoption of robotic surgical platforms.

• NHS surgical modernization drives procurement of automated devices that improve procedure efficiency.
• MIS capability expansion supports growing demand for specialized automated closure instruments.
• Robotic surgery adoption across NHS trusts creates incremental demand for compatible suturing systems.

Competitive Landscape and Strategic Positioning

• Medtronic plc leads through a comprehensive surgical device portfolio including powered suturing instruments integrated with its minimally invasive and robotic surgical platforms.
• Ethicon (Johnson and Johnson) and BD maintain strong positions through established surgical closure portfolios with broad hospital distribution and surgeon familiarity.
• Emerging players are targeting specialized niches including robotic compatible suturing, single port surgery closure, and bariatric procedure specific automated devices.

Medtronic plc maintains a leading position through its comprehensive surgical portfolio spanning powered suturing devices, surgical staplers, and integration with its Hugo robotic surgical platform. Ethicon (Johnson and Johnson) provides a broad range of surgical closure products including powered suturing instruments with established global distribution.

BD (Becton, Dickinson and Company) delivers surgical needles and closure devices. Smith and Nephew provides wound closure products for orthopedic and sports medicine procedures. Boston Scientific offers endoscopic suturing devices for gastrointestinal applications.

Stryker Corporation provides surgical instruments and closure devices across multiple specialties. Corza Medical focuses on specialized surgical suture products.

Barriers to entry include regulatory approval complexity for surgical devices, established surgeon preference and training relationships, hospital group purchasing contracts, and the need for clinical evidence demonstrating safety and efficacy. Strategic priorities include developing robotic surgery compatible devices, expanding single port surgery applications, and building clinical evidence for automated closure benefits.

Key Companies in the Automated Suturing Devices Market

Key global companies leading the automated suturing devices market include:

• Medtronic plc, Ethicon (Johnson and Johnson), Apollo Endosurgery, Inc. maintain leadership through established market presence and product portfolios.
• BD (Becton, Dickinson and Company), Smith and Nephew plc, Boston Scientific Corporation, Stryker Corporation have established positions through specialized capabilities.
• Corza Medical, Peters Surgical, Mellon Medical, Dextera Surgical are among the emerging players gaining traction.

Competitive Benchmarking: Automated Suturing Devices Market

Company	Surgical Portfolio Breadth	MIS Integration	Hospital Access	Geographic Coverage
Medtronic plc	High	High	Strong	Global
Ethicon (J&J)	High	High	Strong	Global
BD	Medium	Medium	Strong	Global
Smith & Nephew	Medium	Medium	Strong	Global
Boston Scientific	Medium	High	Strong	Global
Stryker Corporation	Medium	Medium	Strong	Global
Corza Medical	Low	Medium	Moderate	Global
Peters Surgical	Low	Medium	Moderate	Europe

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Automated Suturing Devices Market

Major Global Players

• Medtronic plc
• Ethicon (Johnson and Johnson)
• Apollo Endosurgery, Inc.
• BD (Becton, Dickinson and Company)
• Smith and Nephew plc
• Boston Scientific Corporation
• Stryker Corporation

Emerging Players/Startups

• Corza Medical
• Peters Surgical
• Mellon Medical
• Dextera Surgical
• LSI Solutions

Report Scope and Coverage

Metric	Value
Quantitative Units	USD 3.85 billion to USD 7.50 billion, at a CAGR of 6.9%
Market Definition	The Automated Suturing Devices Market covers powered and mechanized suturing instruments for tissue approximation and wound closure in surgical procedures.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	USA, UK, Germany, South Korea, Japan, China, India, France, 30 plus countries
Key Companies Profiled	Medtronic plc, Ethicon (Johnson and Johnson), Apollo Endosurgery, BD, Smith and Nephew, Boston Scientific, Stryker Corporation, Corza Medical, Peters Surgical
Forecast Period	2026 to 2036
Approach	Hybrid bottom up and top down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Automated Suturing Devices Market Segmented by Product:

• Disposable
• Reusable

Automated Suturing Devices Market Segmented by Application:

• Minimally Invasive Surgeries
• Open Surgeries
• Trauma Cases

Automated Suturing Devices Market Segmented by End Use:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Automated Suturing Devices Market Segmented by Surgery Type:

• Open Surgery
• Minimally Invasive Surgery

Automated Suturing Devices Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. World Health Organization. (2025). WHO Global Guidelines on Surgical Safety and Infection Prevention. WHO.
• 2. USA Food and Drug Administration. (2025). FDA Medical Device Classification: Automated Surgical Instruments. FDA.
• 3. European Commission. (2024). EU Medical Device Regulation Implementation for Surgical Instruments. EC.
• 4. Association of periOperative Registered Nurses. (2025). AORN Guidelines for Surgical Instrument Processing and Single Use Devices. AORN.
• 5. International Organization for Standardization. (2025). ISO 13485 Quality Management for Medical Devices. ISO.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

• Estimating the market size and revenue projections from 2026 to 2036.
• Segmentation by product, application, end use, and surgery type.
• Regional insights covering more than 30 markets.
• Analysis of product categories including disposable and reusable automated devices.
• Competitive landscape assessment.
• Identification of growth opportunities in robotic surgery, ambulatory surgical centers, and single port procedures.
• Supply chain evaluation.
• Data delivery in PDF and Excel formats.